rs3135802

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_000141.5(FGFR2):​c.1864-17T>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0224 in 1,612,798 control chromosomes in the GnomAD database, including 484 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.021 ( 50 hom., cov: 33)
Exomes 𝑓: 0.023 ( 434 hom. )

Consequence

FGFR2
NM_000141.5 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: -0.345
Variant links:
Genes affected
FGFR2 (HGNC:3689): (fibroblast growth factor receptor 2) The protein encoded by this gene is a member of the fibroblast growth factor receptor family, where amino acid sequence is highly conserved between members and throughout evolution. FGFR family members differ from one another in their ligand affinities and tissue distribution. A full-length representative protein consists of an extracellular region, composed of three immunoglobulin-like domains, a single hydrophobic membrane-spanning segment and a cytoplasmic tyrosine kinase domain. The extracellular portion of the protein interacts with fibroblast growth factors, setting in motion a cascade of downstream signals, ultimately influencing mitogenesis and differentiation. This particular family member is a high-affinity receptor for acidic, basic and/or keratinocyte growth factor, depending on the isoform. Mutations in this gene are associated with Crouzon syndrome, Pfeiffer syndrome, Craniosynostosis, Apert syndrome, Jackson-Weiss syndrome, Beare-Stevenson cutis gyrata syndrome, Saethre-Chotzen syndrome, and syndromic craniosynostosis. Multiple alternatively spliced transcript variants encoding different isoforms have been noted for this gene. [provided by RefSeq, Jan 2009]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BP6
Variant 10-121488130-A-C is Benign according to our data. Variant chr10-121488130-A-C is described in ClinVar as [Benign]. Clinvar id is 255315.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-121488130-A-C is described in Lovd as [Benign].
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.0206 (3123/151502) while in subpopulation NFE AF= 0.0254 (1722/67908). AF 95% confidence interval is 0.0244. There are 50 homozygotes in gnomad4. There are 1511 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 50 Mitochondrial gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
FGFR2NM_000141.5 linkc.1864-17T>G intron_variant Intron 13 of 17 ENST00000358487.10 NP_000132.3 P21802-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
FGFR2ENST00000358487.10 linkc.1864-17T>G intron_variant Intron 13 of 17 1 NM_000141.5 ENSP00000351276.6 P21802-1
FGFR2ENST00000457416.7 linkc.1867-17T>G intron_variant Intron 13 of 17 1 ENSP00000410294.2 P21802-3
FGFR2ENST00000369056.5 linkc.1867-17T>G intron_variant Intron 12 of 16 1 ENSP00000358052.1 P21802-17
FGFR2ENST00000369058.7 linkc.1867-17T>G intron_variant Intron 13 of 16 1 ENSP00000358054.3 A0A5S6RJB7
FGFR2ENST00000613048.4 linkc.1597-17T>G intron_variant Intron 12 of 16 5 ENSP00000484154.1 D2CGD1
FGFR2ENST00000369061.8 linkc.1528-17T>G intron_variant Intron 10 of 14 1 ENSP00000358057.4 P21802-23
FGFR2ENST00000369059.5 linkc.1522-17T>G intron_variant Intron 11 of 15 5 ENSP00000358055.1 E7EVR7
FGFR2ENST00000360144.7 linkc.1600-17T>G intron_variant Intron 12 of 16 2 ENSP00000353262.3 P21802-22
FGFR2ENST00000478859.5 linkc.1180-17T>G intron_variant Intron 12 of 16 1 ENSP00000474011.1 S4R381
FGFR2ENST00000429361.5 linkc.640-17T>G intron_variant Intron 5 of 8 5 ENSP00000404219.1 H7C265
FGFR2ENST00000604236.5 linkn.*911-17T>G intron_variant Intron 12 of 16 1 ENSP00000474109.1 S4R3B2

Frequencies

GnomAD3 genomes
AF:
0.0206
AC:
3124
AN:
151384
Hom.:
50
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0146
Gnomad AMI
AF:
0.0210
Gnomad AMR
AF:
0.0163
Gnomad ASJ
AF:
0.0167
Gnomad EAS
AF:
0.0106
Gnomad SAS
AF:
0.00602
Gnomad FIN
AF:
0.0322
Gnomad MID
AF:
0.0380
Gnomad NFE
AF:
0.0254
Gnomad OTH
AF:
0.0212
GnomAD3 exomes
AF:
0.0191
AC:
4797
AN:
250920
Hom.:
59
AF XY:
0.0191
AC XY:
2588
AN XY:
135654
show subpopulations
Gnomad AFR exome
AF:
0.0148
Gnomad AMR exome
AF:
0.0122
Gnomad ASJ exome
AF:
0.0164
Gnomad EAS exome
AF:
0.0152
Gnomad SAS exome
AF:
0.00519
Gnomad FIN exome
AF:
0.0344
Gnomad NFE exome
AF:
0.0233
Gnomad OTH exome
AF:
0.0243
GnomAD4 exome
AF:
0.0226
AC:
32986
AN:
1461296
Hom.:
434
Cov.:
32
AF XY:
0.0219
AC XY:
15948
AN XY:
726984
show subpopulations
Gnomad4 AFR exome
AF:
0.0169
Gnomad4 AMR exome
AF:
0.0125
Gnomad4 ASJ exome
AF:
0.0166
Gnomad4 EAS exome
AF:
0.00781
Gnomad4 SAS exome
AF:
0.00601
Gnomad4 FIN exome
AF:
0.0349
Gnomad4 NFE exome
AF:
0.0243
Gnomad4 OTH exome
AF:
0.0243
GnomAD4 genome
AF:
0.0206
AC:
3123
AN:
151502
Hom.:
50
Cov.:
33
AF XY:
0.0204
AC XY:
1511
AN XY:
74048
show subpopulations
Gnomad4 AFR
AF:
0.0146
Gnomad4 AMR
AF:
0.0163
Gnomad4 ASJ
AF:
0.0167
Gnomad4 EAS
AF:
0.0106
Gnomad4 SAS
AF:
0.00581
Gnomad4 FIN
AF:
0.0322
Gnomad4 NFE
AF:
0.0254
Gnomad4 OTH
AF:
0.0210
Alfa
AF:
0.0208
Hom.:
7
Bravo
AF:
0.0191
Asia WGS
AF:
0.0150
AC:
53
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:5
Apr 14, 2016
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

-
Genome Diagnostics Laboratory, Amsterdam University Medical Center
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

not provided Benign:2
Apr 29, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: not provided

- -

FGFR2-related craniosynostosis Benign:1
Jan 30, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.83
CADD
Benign
1.2
DANN
Benign
0.61

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs3135802; hg19: chr10-123247644; COSMIC: COSV60640599; COSMIC: COSV60640599; API